Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 28, 2020Annals of TransplantationOpen Access

Effect of Concentration/Dose Ratio in De Novo Kidney Transplant Recipients Receiving LCP-Tacrolimus or Immediate-Release Tacrolimus: Post Hoc Analysis of a Phase 3 Clinical Trial

View Full Paper
Ask AI
Bookmark
Share

Authors

BSBarbara SuwelackSBSuphamai BunnapradistUMUlf Meier‐Kriesche

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Suwelack et al. (2020) studied this question.

synapsesocial.com/papers/6aa398860a4d83fa87b140aahttps://doi.org/10.12659/aot.923278
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Relationship of Tacrolimus Exposure and Mycophenolate Mofetil Dose With Renal Function After Renal Transplantation2011 · 47 citations
  2. 2Long-Term Clinical Impact of Adaptation of Initial Tacrolimus Dosing to CYP3A5 Genotype2016 · 67 citations
  3. 3Prediction of Creatinine Clearance from Serum Creatinine1976 · 15,443 citations
  4. 4Conversion From Twice-Daily Tacrolimus Capsules to Once-Daily Extended-Release Tacrolimus (LCPT)2013 · 101 citations
  5. 5Comparison of Pharmacokinetics and Pathology for Low-Dose Tacrolimus Once-Daily and Twice-Daily in Living Kidney Transplantation2013 · 44 citations